Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

Université de Montréal

$105,000.00

Examining the propagation of non-mutated and long form human tau between the hippocampus and entorhinal cortex in a C57BL/6 mouse model

FY 2023-24

Summary
Tau is an important protein that maintains and regulates our neuronal structures. It does this in part through a protein modification process called phosphorylation. In the healthy state, phosphorylation allows neurons to adapt to environmental changes. However, this process becomes unregulated during Alzheimer's Disease (AD) and creates what is known as tau hyperphosphorylation. Where tau hyperphosphorylation begins in the brain and the patterns in which it spreads have been well defined, but why hyperphosphorylated tau spreads in the patterns observed is not yet known. Some research suggests this propagation is controlled by neuronal structures, while others suggest it is controlled by the speed and direction in which our neurons activate and send signals. To test these theories, our research group will examine an area of the brain called the perforant pathway which is affected in the early stages of AD. This pathway predominantly sends signals in one direction: from the entorhinal cortex to the hippocampus. Using mice, we will inject tau into one of these brain regions per animal. Some animals will receive tau injections in the hippocampus, others in the entorhinal cortex. We theorize that if the propagation of hyperphosphorylated tau is controlled by neuronal structures, it will travel from one region to the other regardless of the injection site. However, if it is controlled by neuronal activity, it will follow the activity of the perforant pathway and travel from the entorhinal cortex to the hippocampus, but not the other way around. Although recent advancements are promising, many drugs developed to treat AD have failed. The objective of this work is to better understand the propagation mechanisms of hyperphosphorylated tau, as slowing its spread may slow cognitive decline. Insights from this project will further our understanding of AD, inform future drug development for this disease, and help improve treatment options for patients.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
496946
Name
Lamontagne-Kam Daniel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Examining the propagation of non-mutated and long form human tau between the hippocampus and entorhinal cortex in a C57BL/6 mouse model
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Atac-Seq; Chronic Injection Models; Hyperphosphorylation; Microscopy; Neurodegeneration; Neuroimaging; Physiology; Rna-Seq; Tau
Abstract
Tau is an important protein that maintains and regulates our neuronal structures. It does this in part through a protein modification process called phosphorylation. In the healthy state, phosphorylation allows neurons to adapt to environmental changes. However, this process becomes unregulated during Alzheimer's Disease (AD) and creates what is known as tau hyperphosphorylation. Where tau hyperphosphorylation begins in the brain and the patterns in which it spreads have been well defined, but why hyperphosphorylated tau spreads in the patterns observed is not yet known. Some research suggests this propagation is controlled by neuronal structures, while others suggest it is controlled by the speed and direction in which our neurons activate and send signals. To test these theories, our research group will examine an area of the brain called the perforant pathway which is affected in the early stages of AD. This pathway predominantly sends signals in one direction: from the entorhinal cortex to the hippocampus. Using mice, we will inject tau into one of these brain regions per animal. Some animals will receive tau injections in the hippocampus, others in the entorhinal cortex. We theorize that if the propagation of hyperphosphorylated tau is controlled by neuronal structures, it will travel from one region to the other regardless of the injection site. However, if it is controlled by neuronal activity, it will follow the activity of the perforant pathway and travel from the entorhinal cortex to the hippocampus, but not the other way around. Although recent advancements are promising, many drugs developed to treat AD have failed. The objective of this work is to better understand the propagation mechanisms of hyperphosphorylated tau, as slowing its spread may slow cognitive decline. Insights from this project will further our understanding of AD, inform future drug development for this disease, and help improve treatment options for patients.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lamontagne-Kam, Daniel
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
Université de Montréal - $105,000 Grant (2023-24) | Canada Spends